Delivery Order SPE2DR25D2103-SPE2DR26F91UK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $5,561.60 for 100 tablets of Concerta ER 18 mg, a controlled-release methylphenidate medication used to treat attention deficit hyperactivity disorder. The award, issued on November 24, 2025, represents a firm fixed-price delivery order with an ultimate completion date of November 25, 2025. The contract utilizes no set-aside designation and was competitively awarded. AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $9,598.74 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 36 mg, a controlled-release methylphenidate medication used to treat attention-deficit/hyperactivity disorder. This competitively awarded, firm fixed-price delivery order, issued on November 5, 2025, will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility and is scheduled for completion by November 6, 2025. No small business set-aside was utilized...
- The Defense Logistics Agency Medical Supply Chain awarded a $21,395.38 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Concerta ER Tabs 36mg, a controlled-release methylphenidate medication used to treat attention-deficit/hyperactivity disorder. The contract is a firm fixed price delivery order with an ultimate completion date of July 21, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This award was competitively awarded...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,010.89 to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 54 mg, a prescription medication used to treat attention deficit hyperactivity disorder. This competitively awarded, firm fixed-price delivery order was issued on October 23, 2025, with an ultimate completion date of October 24, 2025, and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The place of...
- The Defense Logistics Agency's Medical Supply Chain awarded a $5,190.36 delivery order to AmerisourceBergen Drug Corp for Concerta ER Tablets 36mg, a controlled-release methylphenidate medication used to treat attention-deficit/hyperactivity disorder. This firm fixed-price delivery order, issued on October 29, 2025, represents a competitive award with no set-aside designation and is scheduled for completion by October 30, 2025. The order will be fulfilled from AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,196.31 to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 18 mg, a prescription medication used to treat attention deficit hyperactivity disorder. This firm fixed price, non-set-aside contract was awarded on December 1, 2025, with completion scheduled for December 2, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 1, 2025, for the supply of Concerta ER Tablets 36mg, a controlled-release methylphenidate product commonly used for attention deficit hyperactivity disorder treatment. This firm fixed-price delivery order, valued at $17,783.70 with an ultimate completion date of July 2, 2025, was competitively awarded without set-aside provisions and will be performed at the contractor's...
- The Defense Logistics Agency awarded a $4,216.36 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Concerta 54mg, a prescription medication commonly used to treat attention deficit hyperactivity disorder. This non-set-aside contract represents a firm fixed price delivery order with an ultimate completion date of December 2, 2025. The award was made to the vendor's corporate office located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters. This...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Concerta ER Tablets 36mg, a controlled-release methylphenidate medication used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order, valued at $67,832.46, represents a competitively awarded, non-set-aside contract with an ultimate completion date of August 28, 2025. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $9,872.70 to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 27 mg, a controlled-release methylphenidate medication used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by August 18, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- SPE2DR25D2103Indefinite Delivery Contract
- SPE2DR25D2103-SPE2DR26F91UKDelivery Order
The Defense Logistics Agency awarded a $15,198.99 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 36 mg, a controlled-release methylphenidate medication used to treat attention deficit hyperactivity disorder. The contract is a firm fixed-price delivery order with an ultimate completion date of December 18, 2025, and was competitively awarded without set-aside provisions. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a prime contractor for this pharmaceutical supply requirement. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive IDC enables the company to supply pharmaceuticals and medical supplies to support military healthcare programs globally. AmerisourceBergen's extensive federal contract portfolio with the Defense Logistics Agency demonstrates its capability to meet recurring medical procurement needs across therapeutic domains, servicing customers including the Defense Health Agency and U.S. Coast Guard through flexible contract vehicles designed to support military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.2k | 12/16/25 |